Treatment of persistent COVID-19 in two B-cell-depleted patients with the monoclonal antibody Sotrovimab

BACKGROUND: Patients having undergone B-cell-depletion with anti-CD20-antibodies have a higher risk of mortality, delayed viral clearance and prolonged infection due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We report two cases of patients with persistent coronavirus disease 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Totschnig, David, Doberer, Daniel, Haberl, Renate, Wenisch, Christoph, Valipour, Arschang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172259/
https://www.ncbi.nlm.nih.gov/pubmed/35694274
http://dx.doi.org/10.1016/j.idcr.2022.e01528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172259/
https://www.ncbi.nlm.nih.gov/pubmed/35694274
http://dx.doi.org/10.1016/j.idcr.2022.e01528

Ejemplares similares